Showing results (411-420 of 579) with videos related to

Sort By:
Pageof 58
International Journal of Cardiology|February 19, 2025
A 2D-STI echocardiographic diagnostic model established for cardiac amyloidosis complicated with multiple myelomaHongmiao Shen, Jiali Fan, Xingyue Wu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 29, 2021
Phase 1 studies comparing safety, tolerability, pharmacokinetics and pharmacodynamics of HLX01 (a rituximab biosimilar) to reference rituximab in Chinese patients with CD20-positive B-cell lymphomaYuankai Shi, Qingyuan Zhang, Xiaohong Han, et al.
Frontiers in Oncology|October 8, 2021
Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell TransplantationLimin Liu, Xin Zhao, Miao Miao, et al.
Nature Communications|June 20, 2023
Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myelomaDongpeng Jiang, Haiwen Huang, Huimin Qin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 25, 2013
The expression of Th17-associated cytokines in human acute graft-versus-host diseaseYuejun Liu, Yifeng Cai, Lan Dai, et al.
Blood|June 11, 2026
A novel triple-knockout allogeneic BCMA CAR T cell therapy (CT0590) in multiple myeloma: preclinical and phase I studySong Jin, Zhaohui Liao, Shuang Yan, et al.
Signal Transduction and Targeted Therapy|May 5, 2024
Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trialBiqi Zhou, Jia Chen, Tianhui Liu, et al.
Bone Marrow Transplantation|September 15, 2025
Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationYuhua Ru, Jia Chen, Allain-Thibeault Ferhat, et al.
Cells|January 20, 2021
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T CellsWenjie Gong, Lei Wang, Sophia Stock, et al.
British Journal of Haematology|August 18, 2018
Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)Jonathan Canaani, Myriam Labopin, Xiao J Huang, et al.
Pageof 58